Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650
Background: The epithelial layer of the nasal mucosa is the first barrier for drug permeation during intranasal drug delivery. With increasing interest for intranasal pathways, adequate in vitro models are required. Here, porcine olfactory (OEPC) and respiratory (REPC) primary cells were characteris...
Saved in:
Main Authors: | Simone Ladel (Author), Patrick Schlossbauer (Author), Johannes Flamm (Author), Harald Luksch (Author), Boris Mizaikoff (Author), Katharina Schindowski (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
by: Nadica Sibinovska, et al.
Published: (2022) -
Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?
by: Simone Ladel, et al.
Published: (2018) -
A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro
by: Sara Wong, et al.
Published: (2024) -
Investigation of the inhibitory effects of simvastatin in RPMI 2650: an in-vitro study / Jaapar K. H. ... [et al.]
by: Jaapar, K.H, et al.
Published: (2022) -
Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
by: Stella Gänger, et al.
Published: (2018)